EW vs HXL · P/E 47, rev $3.39B vs P/E 59, rev $529.3M
Edwards Lifesciences Corp (EW) versus Hexcel Corporation (HXL) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Hexcel Corporation (HXL) is a aerospace & defense company listed on US.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported HXL revenue for 2026-06-30 was $529.3M. Net income was $49.3M. Revenue was up 5.5% from 2026-03-31 to 2026-06-30. HXL currently screens at market cap $6.73B and trailing P/E 59.0.
EW currently screens at market cap $49.91B and trailing P/E 46.9. HXL currently screens at market cap $6.73B and trailing P/E 59.0.
Not investment advice. Open the EW and HXL stock pages for the full models.
Not investment advice.